Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) covers events occurring on November 5, 2017, with a report date of November 6, 2017. The filing primarily addresses significant changes in corporate governance and management, specifically the appointment of a new Chief Executive Officer and the transition of the former CEO.
Key Financial Metrics and Compensation
The filing does not report operational financial metrics such as revenue, profit, cash flow, or debt levels for the period. Instead, it details specific compensation figures related to executive appointments:
- New CEO Base Salary: $1,400,000 annually for Gail Boudreaux.
- New CEO Target Bonus: 175% of base salary (starting fiscal year 2018).
- New CEO Long-Term Incentives: Aggregate target value of $10,250,000 for 2018.
- New CEO Sign-On Grant: Performance stock units with a target value of $2,000,000.
- Former CEO Transition Compensation: Joseph Swedish will receive $4,500,000 per year as Senior Advisor and Consultant from May 31, 2018, through May 1, 2020.
Material Changes Versus Prior Period
The primary material change is the leadership transition:
- Appointment of CEO: Gail Boudreaux was appointed Chief Executive Officer and President, effective November 20, 2017. She also joined the Board of Directors.
- Departure of CEO: Joseph Swedish stepped down as CEO to become Executive Chairman until the earlier of the 2018 annual meeting or May 31, 2018, followed by a role as Senior Advisor.
Guidance, Outlook, and Risks
Financial Guidance: The company reaffirmed its full-year 2017 net income guidance:
- Reported Net Income: $10.80 to $10.90 per share (includes approximately $1.10 per share of net unfavorable items).
- Adjusted Net Income: $11.90 to $12.00 per share (excluding the unfavorable items).
Risks and Contingencies: The filing highlights several material risks, including:
- Litigation: Ongoing litigation with Cigna Corporation regarding a failed merger, involving claims for damages and termination fees.
- Regulatory Environment: Impacts of the Affordable Care Act, potential repeal or modification of health care reform, and state guaranty fund assessments.
- Cybersecurity: Continued risks related to the February 2015 cyber attack and unauthorized disclosure of sensitive information.
- Market Conditions: Trends in health care costs, premium rate adequacy, and competition.
Investor Verification Checklist
- Verify the exact terms of the employment agreement and transition agreement filed as Exhibits 10.1 and 10.2.
- Monitor the status and potential financial impact of the litigation with Cigna Corporation.
- Review the company's ability to meet the reaffirmed 2017 net income guidance given the cited unfavorable items.
- Assess the impact of the leadership transition on strategic direction and operational stability.
- Track updates regarding the 2015 cyber attack investigations and associated liabilities.